维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="EFFICACE F"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Which health - related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group显示文摘	Efficace F Breccia M Saussele S	2012	Ann Hematol2012，91，9：	1
2	Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of- life outcomes显示文摘	Efficace F MandeUi F Avvisati G	2014	J Clin Oncol2014，32，30：	1
3	Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid显示文摘	Breccia M Molica M Efficace F	2014	BrJ Haematol2014，167，3：	1
4	Symptoms and patient-reported well-being:do they predict survival in malignant pleuralmesothelioma?A prognostic factor analysis of EORTC-NCIC08983 randomized phase Ⅲ study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma显示文摘	Bettomley A Coens C Efficace F et el	2007	J Clin Oncul2007，25，36：	1
5	Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population显示文摘	Efficace F Baccarani M Breccia M	2011	Blood2011，118，17：	1
6	Patient-reported outcomes after neoadjuvantchemoradiotherapy for rectal cancer: a multi-center prospective observational study 显示文摘	Pucciarelli S Del Bianco P Efficace F	2011	Ann Surg2011，253，1：	1
7	Health-related quality of life parameters as prognostic factors in a non meta static breast cancer population: a international multicenter study显示文摘	Efficace F Therasse P Piccart M	2004	J Clin Oncol2004，22，16：	1
8	Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group显示文摘	Efficace F Breccia M Saussele S	2012	Ann Hemato12012，91，9：	1
9	Cross-cultural develop- ment of the EORTC QLQ-SWB36:A stand-alone measure of spirit- ual well-being for palliative care patients with cancer 显示文摘	VlVAT B YOUNG T EFFICACE F	2013	Palliat Meal2013，27，5：	1
10	Symptoms and patient-reported well-being:do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983:randomized phase Ⅲ study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma显示文摘	Bottomley A Coens C Efficace F	2007	J Clin Oncol2007，25，36：	1
11	Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: inclusion of quality of life and other patient-reported outcomes 显示文摘	Efficace F Cocks K Breccia M	2012	Crit Rev Oneol Hematol2012，81，2：	1
12	Symptoms and patientreported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTCNCIC 08983: randomized phase Ⅲ study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma显示文摘	Bottomley A Coens C Efficace F	2007	J Clin Oncol2007，25，36：	1
13	Investigating factors associ- ated with adherence behaviour in patients with chronic myeloid leukemia:an observational patient-centered outcome study显示文摘	Efficace F Baccarani M Rosti G	2012	Br J Cancer2012，107，6：	1
14	Chronic fatigue is the most important factor limiting health-related quality of life of chron- ic myeloid leukemia patients treated with imatinib 显示文摘	Efficace F Baccarani M Breccia M	2013	Leukemia2013，27，7：	1
15	Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia:an observational patient-centered outcome study显示文摘	Efficace F Baccarani M Rosti G	2012	Br J Cancer2012，107，6：	1
16	Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib 显示文摘	Efficace F Baccarani M Breccia M	2013	Leukemia2013，27，7：	1
17	Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health careprofessionals? GIMEMA and EORTC Quality of Life Group 显示文摘	Efficace F Breccia M Saussele S	2012	Ann Hematol2012，91，9：	1
18	Imatinib treatment in chronic myelogenous leukemia: What have we learned so far? 显示文摘	BRECCIA M EFFICACE F ALIMENA G	2011	CancerLett2011，300，2：	1
19	Health-related quality of life in chronic myeloid leukemia patients receiving long-termtherapy with imatinib compared with the general population 显示文摘	Efficace F Baccarani M Breccia M	2011	Blood2011，118，17：	1
20	Health related quality of life outcomes in cancer clinical trials 显示文摘	Bottomley A Flechtner H Efficace F	2005	Eur J Cancer2005，41，12：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示